Ehrlichia ewingii in an immunocompetent adult.
The third Ehrlichia infection described in humans in the United States is reviewed. This rare zoonosis was first published in 1999. This case report that expands the clinical paradigm is described. A 57-year-old immunocompetent adult, unlike previously published reports, did not cross react with Ehrlichia chaffeensis.
Masters
Edwin J
EJ
Washington University School of Medicine, USA.
Storch
Gregory A
GA
Sumner
John W
JW
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000942:Antigens, Bacterial / Q000032:analysis; D003429:Cross Reactions; D004318:Doxycycline / Q000627:therapeutic use; D016873:Ehrlichiosis / Q000175:diagnosis / Q000276:immunology*; D006801:Humans; D007121:Immunocompetence; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction
D000900:Anti-Bacterial Agents; D000942:Antigens, Bacterial; D004318:Doxycycline